Adient plc
NYSE:ADNTAuto - Parts
+$0.21 today
- Market cap
- $1.15B
- Beta
- 1.51
- P/E (TTM)
- 27.8
- EPS (TTM)
- $0.74
Volume 1.72M
Average 0.97M
ADNT Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Adient plcNYSE: ADNT
Free Cash Flow · Q2 FY2026 · quarter ended Mar 2026
Free cash flow turns positive
Q2 FY2026 free cash flow was $14M, compared with -$89M a year earlier. Trailing-twelve-month free cash flow was $278M. Over 3 fiscal years it compounded at +63.1% a year.
Context
- Free cash flow amounted to 1.4% of revenue in FY2025, down 0.5 pp from a year earlier.
- Free cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly free cash flow holds near $14M or moves back toward the trailing-twelve-month quarterly average of $69.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 204M USD
- Year-over-year change
- -26.4%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 204M | -26.4% |
| FY2024 | 2024-09-30 | 277M | -33.3% |
| FY2023 | 2023-09-30 | 415M | +783.0% |
| FY2022 | 2022-09-30 | 47M | — |
| FY2021 | 2021-09-30 | 0 | — |
Free Cash Flow vs competitors
How ADNT compares with its peers on the latest reported figures
- ADNT's LTM Mar 2026 free cash flow of $278M is the 6th largest of the 14 companies compared; the peer median is $70.44M.
- Its year-over-year change of +18.3% is the 7th highest of 14, against a peer median of -4.6%.
- Free cash flow amounts to 1.9% of revenue for ADNT, versus a peer median of 3.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.09B | -7847.0% | +31.4% | 602.3% | |
| LTM Sep 2026 | $825M | +20.4% | +9.8% | 18.2% | |
| LTM Jun 2026 | $756M | +68.0% | +77.4% | 6.8% | |
| LTM Oct 2026 | $700.8M | -4.6% | +11.2% | 2.9% | |
| LTM Jun 2026 | $496.65M | +22.7% | +33.7% | 18.9% | |
| LTM Mar 2026 | $278M | +18.3% | +63.1% | 1.9% | |
| LTM Jun 2026 | $160M | -51.7% | +47.7% | 4.2% | |
| LTM Jun 2026 | $132M | +187.0% | +12.6% | — | |
| LTM Mar 2026 | $70.44M | -33.3% | -39.6% | 6.1% | |
| LTM Mar 2026 | $39.4M | +106.0% | — | 2.2% | |
| LTM Mar 2026 | $18.4M | +155.4% | -11.6% | 2.8% | |
| LTM Apr 2026 | $11.87M | -85.6% | -42.7% | 0.8% | |
| LTM Mar 2026 | $8.19M | -132.8% | — | 1.0% | |
| LTM Mar 2026 | $1.06M | -97.4% | — | 0.1% | |
| Peer median (excluding ADNT) | $70.44M | -4.6% | +11.9% | 3.6% | |
Competitors are the stored peer set for ADNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 1.11B | (40M) | 295M | 101M | (281M) |
| Depreciation & Amortization | 330M | 350M | 340M | 332M | 325M |
| Deferred Income Tax | 40M | (25M) | (124M) | (1M) | (28M) |
| Stock-Based Compensation | 0 | 29M | 34M | 31M | 0 |
| Change in Working Capital | (227M) | (108M) | 126M | 75M | (45M) |
| Accounts Receivables | 483M | (576M) | 16M | 12M | 31M |
| Inventory | (263M) | (62M) | 126M | 93M | 75M |
| Accounts Payables | (388M) | 558M | (19M) | 90M | (61M) |
| Other Working Capital | (59M) | (28M) | 3M | (120M) | (90M) |
| Other Non-Cash Items | (991M) | 68M | (4M) | 5M | 478M |
| Operating Cash Flow | 260M | 274M | 667M | 543M | 449M |
| Capital Expenditures | (260M) | (227M) | (252M) | (266M) | (245M) |
| Acquisitions (Net) | 604M | 721M | (1M) | (2M) | 88M |
| Purchases of Investments | 0 | (30M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 3M | 20M | 24M | 15M | (29M) |
| Investing Cash Flow | 347M | 484M | (229M) | (253M) | (186M) |
| Debt Repayment | (694M) | (1B) | (103M) | (138M) | (20M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (65M) | (275M) | (125M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (76M) | (272M) | (103M) | (89M) | (122M) |
| Financing Cash Flow | (770M) | (1.27B) | (271M) | (502M) | (267M) |
| Effect of Forex Changes | (8M) | (59M) | (4M) | 47M | 17M |
| Net Change in Cash | (171M) | (574M) | 163M | (165M) | 13M |
| Free Cash Flow | 0 | 47M | 415M | 277M | 204M |
Adient plc
NYSE:ADNT
Intrinsic Alpha fair value
Locked
Current Price
$15.44
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.